| LP248693-6 | Norsufentanil | COMPONENT | 2 |
| LP248694-4 | Facility | CLASS | |
| LP248697-7 | Identification numbers | CLASS | |
| LP248700-9 | Date of condition onset | COMPONENT | 1 |
| LP248706-6 | PRRSV European and North American strains IgG panel | COMPONENT | 1 |
| LP248715-7 | Clot formation+Clotting time | COMPONENT | 1 |
| LP248725-6 | Epilepsy | METHOD | 2 |
| LP248726-4 | Epilepsy | Document.SubjectMatterDomain | 2 |
| LP248727-2 | Sleep medicine | METHOD | 13 |
| LP248728-0 | Sleep medicine | Document.SubjectMatterDomain | 14 |
| LP248729-8 | Neuropsychology | Document.SubjectMatterDomain | 7 |
| LP248730-6 | Neuropsychology | METHOD | 7 |
| LP248731-4 | Womens health | METHOD | 13 |
| LP248732-2 | Womens health | Document.SubjectMatterDomain | 16 |
| LP248733-0 | Womens health Nurse | METHOD | 2 |
| LP248734-8 | Womens health Nurse practitioner | METHOD | 1 |
| LP248735-5 | Recovery room | SYSTEM | 3 |
| LP248736-3 | Recovery room | Document.Setting | 3 |
| LP248737-1 | Teleimaging | Document.Setting | 3 |
| LP248738-9 | Teleimaging | SYSTEM | 3 |
| LP248739-7 | Medical clearance note | COMPONENT | 2 |
| LP248740-5 | Medical clearance note | Document.Kind | 2 |
| LP248741-3 | Cardiothoracic surgery Interdisciplinary | METHOD | 1 |
| LP248742-1 | Cardiothoracic surgery Nurse | METHOD | 1 |
| LP248745-4 | Disease staging note | COMPONENT | 2 |
| LP248746-2 | Clinical cardiac electrophysiology | METHOD | 9 |
| LP248751-2 | Gastrointestinal tract upper and Gallbladder | SYSTEM | 1 |
| LP248752-0 | Gastrointestinal tract upper and Small bowel and Gallbladder | SYSTEM | 1 |
| LP248760-3 | Urinary bladder arteries | SYSTEM | 1 |
| LP248769-4 | Date of influenza vaccination | COMPONENT | 1 |
| LP248773-6 | Guidance for placement of prosthesis | COMPONENT | |
| LP248775-1 | Physical score | COMPONENT | 1 |
| LP248776-9 | Emotional score | COMPONENT | 1 |
| LP248777-7 | IRF-PAI - Physical therapy - week 2 | COMPONENT | 1 |
| LP248778-5 | IRF-PAI - Occupational therapy - week 2 | COMPONENT | 1 |
| LP248779-3 | IRF-PAI - Speech-language pathology services - week 2 | COMPONENT | 1 |
| LP248780-1 | Thymidine synthase activity interpretation | COMPONENT | 1 |
| LP248781-9 | National Kidney Disease Education Program | METHOD | 1 |
| LP248896-5 | LCDS v3.00 - Cognitive patterns | COMPONENT | 1 |
| LP248897-3 | Is there evidence of an acute change in mental status from the patient's baseline during 3 day assessment period | COMPONENT | 1 |
| LP248898-1 | Did the (abnormal) behavior fluctuate during the day, that is, tend to come and go or increase and decrease in severity during 3 day assessment period | COMPONENT | 1 |
| LP248899-9 | Did the patient have difficulty focusing attention, for example, being easily distractible or having difficulty keeping track of what was being said during 3 day assessment period | COMPONENT | 1 |
| LP248900-5 | Was the patient's thinking disorganized or incoherent, such as rambling or irrelevant conversation, unclear or illogical flow of ideas, or unpredictable switching from subject to subject during 3 day assessment period | COMPONENT | 1 |
| LP248907-0 | Level of consciousness - Alert (normal) during 3 day assessment | COMPONENT | 1 |
| LP248908-8 | Level of consciousness - Vigilant or lethargic or stupor or coma during 3 day assessment | COMPONENT | 1 |
| LP248909-6 | Retinal nerve fiber layer panel | COMPONENT | 1 |
| LP248910-4 | LCDS v3.00 - Functional abilities and goals | COMPONENT | 1 |
| LP248930-2 | Wash upper body - functional ability during 3 day assessment period | COMPONENT | 1 |
| LP248931-0 | Wash upper body - functional goal during 3 day assessment period | COMPONENT | 1 |
| LP248937-7 | Indicate the patient's primary medical condition category during 3 day assessment period | COMPONENT | 1 |